A. Sloan (ed.)Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies
Valuing Health Care
Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies
Herausgeber: Sloan, Frank A.
A. Sloan (ed.)Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies
Valuing Health Care
Costs, Benefits, and Effectiveness of Pharmaceuticals and Other Medical Technologies
Herausgeber: Sloan, Frank A.
- Broschiertes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
This book is about the cost effectiveness of present and future medical technologies.
Andere Kunden interessierten sich auch für
Sunder FriedmanExperimental Methods68,99 €
J. Alston / Thrainn Eggertsson / C. North (eds.)Empirical Studies in Institutional Change39,99 €
Pietro NavarraThe Economics of Freedom42,99 €
Malcolm GladwellDavid and Goliath22,99 €
Helen PearsonThe Life Project14,99 €
Rafael D. KasischkeThe Happy Money14,90 €
Mike Berners-LeeA Climate of Truth12,99 €-
-
-
This book is about the cost effectiveness of present and future medical technologies.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 288
- Erscheinungstermin: 4. September 2002
- Englisch
- Abmessung: 229mm x 152mm x 18mm
- Gewicht: 471g
- ISBN-13: 9780521576468
- ISBN-10: 0521576466
- Artikelnr.: 21198159
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
- Verlag: Cambridge University Press
- Seitenzahl: 288
- Erscheinungstermin: 4. September 2002
- Englisch
- Abmessung: 229mm x 152mm x 18mm
- Gewicht: 471g
- ISBN-13: 9780521576468
- ISBN-10: 0521576466
- Artikelnr.: 21198159
- Herstellerkennzeichnung
- Libri GmbH
- Europaallee 1
- 36244 Bad Hersfeld
- gpsr@libri.de
1. Introduction Frank A. Sloan; 2. Evidence of effectiveness: evaluating
its quality Allan S. Detsky; 3. Utility assessment for estimating
quality-adjusted life years Robert M. Kaplan; 4. Measuring costs David
Dranove; 5. From cost-effectiveness ratios to resource allocation: where to
draw the line? Milton C. Weinstein; 6. Valuing health care benefits in
money terms Mark V. Pauly; 7. Discounting health effects for medical
decisions W. Kip Viscusi; 8. Statistical issues in cost-effectiveness
analyses John Mullahy and Willard Manning; 9. Decision trees and Markov
models in cost-effectiveness research Emmett Keeler; 10. Alternative
methods of allocating health resources under constraints Frank A. Sloan and
Christopher J. Conover.
its quality Allan S. Detsky; 3. Utility assessment for estimating
quality-adjusted life years Robert M. Kaplan; 4. Measuring costs David
Dranove; 5. From cost-effectiveness ratios to resource allocation: where to
draw the line? Milton C. Weinstein; 6. Valuing health care benefits in
money terms Mark V. Pauly; 7. Discounting health effects for medical
decisions W. Kip Viscusi; 8. Statistical issues in cost-effectiveness
analyses John Mullahy and Willard Manning; 9. Decision trees and Markov
models in cost-effectiveness research Emmett Keeler; 10. Alternative
methods of allocating health resources under constraints Frank A. Sloan and
Christopher J. Conover.
1. Introduction Frank A. Sloan; 2. Evidence of effectiveness: evaluating
its quality Allan S. Detsky; 3. Utility assessment for estimating
quality-adjusted life years Robert M. Kaplan; 4. Measuring costs David
Dranove; 5. From cost-effectiveness ratios to resource allocation: where to
draw the line? Milton C. Weinstein; 6. Valuing health care benefits in
money terms Mark V. Pauly; 7. Discounting health effects for medical
decisions W. Kip Viscusi; 8. Statistical issues in cost-effectiveness
analyses John Mullahy and Willard Manning; 9. Decision trees and Markov
models in cost-effectiveness research Emmett Keeler; 10. Alternative
methods of allocating health resources under constraints Frank A. Sloan and
Christopher J. Conover.
its quality Allan S. Detsky; 3. Utility assessment for estimating
quality-adjusted life years Robert M. Kaplan; 4. Measuring costs David
Dranove; 5. From cost-effectiveness ratios to resource allocation: where to
draw the line? Milton C. Weinstein; 6. Valuing health care benefits in
money terms Mark V. Pauly; 7. Discounting health effects for medical
decisions W. Kip Viscusi; 8. Statistical issues in cost-effectiveness
analyses John Mullahy and Willard Manning; 9. Decision trees and Markov
models in cost-effectiveness research Emmett Keeler; 10. Alternative
methods of allocating health resources under constraints Frank A. Sloan and
Christopher J. Conover.







